Momelotinib is a tyrosine kinase inhibitor utilized as an antineoplastic agent in the treatment of myelofibrosis. This category provides a comprehensive range of reference standards, including the active… Read more










Momelotinib is a tyrosine kinase inhibitor utilized as an antineoplastic agent in the treatment of myelofibrosis. This category provides a comprehensive range of reference standards, including the active pharmaceutical ingredient (API), associated impurities, and metabolites required for rigorous analytical testing. Pharmaceutical laboratories rely on these compounds for impurity profiling, method validation, and routine quality control to ensure regulatory compliance. The inclusion of stable isotope labelled compounds, such as deuterium-labelled versions of the parent drug, allows for precise quantitative analysis and serves as an essential internal standard in mass spectrometry-based assays. By providing access to these specialized materials, including specific N-cyanomethyl derivatives and identified metabolites, laboratories can effectively monitor drug quality and stability throughout the manufacturing process.